Views & Analysis | Perspectives on pharma industry issues

Digital

Two female silhouettes in a city office overlook the urban landscape below

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Articles

Rare diseases, orphan drugs and parent companies

Catherine McLoughlin discusses the investments of pharma and biotech companies in the orphan drug market. If, early on in my career as a lawyer in the life sciences sector, I had a £1.00 for every deal that I did for a biotech company...

Articles

Rare diseases part 1: posing questions that are difficult to...

Starting off our rare diseases focus month, Neil Dickinson discusses the impact of orphan drug development, looking at legislation changes and his own personal experiences. The pharmaceutical industry has always been different to most other commercial sectors and almost every point of difference...

Articles

Gathering momentum to tackle antimicrobial resistance

We interview Dr John Rex of AstraZeneca to get an update on the NewDrugs4BadBugs programme and the challenge of antimicrobial resistance in general. Following on from our recent blog post by Dr John Rex we interview him for an update on the Innovative Medicines Initiative’s...

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access